IRS an ‘unlikely savior’ of quarterly results, analysts say
Bristol Myers Squibb Co. shares BMY, -3.43% were down more than 4% in early trading on Thursday after the drugmaker reported third-quarter results that topped analysts’ estimates, but some key products fell short of expectations.
Global sales of cancer drug Opdivo came to $2.275 billion, up 11% from the year earlier but falling short of analyst expectations. Melanoma drug Opdualag also missed estimates, with global sales of $166 million. The company pushed back the timeline for its overall new product portfolio to top $10 billion in revenues to 2026, versus previous guidance of 2025.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Bristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Lire la suite »
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
Lire la suite »
Bristol Myers Revenue Declines but Beats Expectations as Revlimid Sales DropThe drugmaker reports third-quarter earnings of $2 a share on revenue of $10.97 billion.
Lire la suite »
Bristol Myers says it needs another year to hit target for new drugsDrugmaker Bristol Myers Squibb (BMY.N) on Thursday pushed back by a year the time frame for its current new-product portfolio to hit $10 billion in sales as the ramp-up of new drugs including anemia treatment Reblozyl, psoriasis drug Sotyktu, and multiple sclerosis drug Zeposia takes longer than expected.
Lire la suite »
Turning Michael Myers Into a Supernatural Cult Monster Made Him Less ScaryHalloween: The Curse of Michael Myers introduces the Cult of Thorn and tries to give the iconic killer an unneeded backstory.
Lire la suite »
De La Ghetto, Bryant Myers, Luar La L & YOVNGCHIMI Debut on Hot 100All 21 songs from Bad Bunny’s new LP chart on the Hot 100.
Lire la suite »